BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5113821)

  • 21. [3 years' experience with an original antidepressive drug in 120 patients].
    Jarret R; Giraud J; Tristan M; Alliez MJ
    Ann Med Psychol (Paris); 1973 Jan; 1(1):143-53. PubMed ID: 4723204
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study of the activity of sismotherapy and chemotherapy on the evolution of depressions by statistical methods].
    Gayral L; Raymondis LM; Schecktman Y; Privat C
    Encephale; 1969; 58(1):5-18. PubMed ID: 5385378
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined therapy in endogenous depression].
    Bilikiewicz A
    Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1153-7. PubMed ID: 5993463
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].
    Mashkovskii MD; Polezhaeva AI; Avrutskii GIa; Vertozgadova OP; Smulevich AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1234-8. PubMed ID: 5392529
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent vital depressions. A follow-up study of 56 female and 28 male patients.
    van Scheyen JD
    Psychiatr Neurol Neurochir; 1973; 76(2):93-112. PubMed ID: 4700934
    [No Abstract]   [Full Text] [Related]  

  • 27. A closer look at treatment resistant depression: is it due to a bipolar diathesis?
    Sharma V; Khan M; Smith A
    J Affect Disord; 2005 Feb; 84(2-3):251-7. PubMed ID: 15708423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Trial of G. 35020 in 52 cases of depression].
    Margat P; Broussot T; Pouly JP
    Ann Med Psychol (Paris); 1968 Jan; 1(1):126-32. PubMed ID: 5651940
    [No Abstract]   [Full Text] [Related]  

  • 29. To the antidepressive properties of lithium and its place in the group of antidepressive drugs.
    Náhunek K; Svestka J; Rodová A
    Act Nerv Super (Praha); 1971; 13(3):169-70. PubMed ID: 4939828
    [No Abstract]   [Full Text] [Related]  

  • 30. Measurement of mood.
    Zealley AK; Aitken RC
    Proc R Soc Med; 1969 Oct; 62(10):993-6. PubMed ID: 5346176
    [No Abstract]   [Full Text] [Related]  

  • 31. [Imipramine-desipramine association in depressive syndromes: EEG study during spontaneous sleep].
    Rizzitelli F; Spina A
    Acta Neurol (Napoli); 1973; 28(5):580-7. PubMed ID: 4363739
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of drug effects in newly hospitalized depressives.
    Rockliff BW
    Dis Nerv Syst; 1971 Aug; 32(8):532-7. PubMed ID: 4937543
    [No Abstract]   [Full Text] [Related]  

  • 33. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of bipolar depression.
    Dubovsky SL
    Psychiatr Clin North Am; 2005 Jun; 28(2):349-70, vii. PubMed ID: 15826736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
    Cassidy F
    Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical therapy of depressive syndromes with Noxiptilin].
    Hohnbaum M; Sattes H
    Arzneimittelforschung; 1970 Jul; 20(7):940-3. PubMed ID: 5536065
    [No Abstract]   [Full Text] [Related]  

  • 37. Scopolamine sleep treatment in private practise.
    Goldner RD
    Int J Neuropsychiatry; 1967 Jun; 3(3):234-47. PubMed ID: 6039771
    [No Abstract]   [Full Text] [Related]  

  • 38. Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy.
    Okamoto H; Shimizu E; Ozawa K; Hashimoto K; Iyo M
    Aust N Z J Psychiatry; 2005; 39(1-2):108. PubMed ID: 15660714
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression.
    Agosti V; Stewart JW
    Int Clin Psychopharmacol; 2007 Sep; 22(5):309-11. PubMed ID: 17690600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity.
    Inoue T; Nakagawa S; Kitaichi Y; Izumi T; Tanaka T; Masui T; Kusumi I; Denda K; Koyama T
    J Affect Disord; 2006 Oct; 95(1-3):61-7. PubMed ID: 16797078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.